Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study

New α,β-unsaturated ketones 4a,b; 5a–c; and 6a,b; as well as 4-H pyran 7; pyrazoline 8a,b; isoxazoline 9; pyridine 10–11; and quinoline-4-carboxylic acid 12a,b derivatives were synthesized and evaluated for in vitro antitumour activity against HepG2, MCF-7, HeLa, and PC-3 cancer cell lines. Antioxid...

Full description

Bibliographic Details
Main Authors: Walaa M. El-Husseiny, Magda A.-A. El-Sayed, Naglaa I. Abdel-Aziz, Adel S. El-Azab, Esam R. Ahmed, Alaa A.-M. Abdel-Aziz
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:http://dx.doi.org/10.1080/14756366.2018.1434519
_version_ 1818295928650465280
author Walaa M. El-Husseiny
Magda A.-A. El-Sayed
Naglaa I. Abdel-Aziz
Adel S. El-Azab
Esam R. Ahmed
Alaa A.-M. Abdel-Aziz
author_facet Walaa M. El-Husseiny
Magda A.-A. El-Sayed
Naglaa I. Abdel-Aziz
Adel S. El-Azab
Esam R. Ahmed
Alaa A.-M. Abdel-Aziz
author_sort Walaa M. El-Husseiny
collection DOAJ
description New α,β-unsaturated ketones 4a,b; 5a–c; and 6a,b; as well as 4-H pyran 7; pyrazoline 8a,b; isoxazoline 9; pyridine 10–11; and quinoline-4-carboxylic acid 12a,b derivatives were synthesized and evaluated for in vitro antitumour activity against HepG2, MCF-7, HeLa, and PC-3 cancer cell lines. Antioxidant activity was investigated by the ability of these compounds to scavenge the 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS•+). Compounds 6a, 6b, 7, and 8b exhibited potent antitumour activities against all tested cell lines with [IC50] ≅5.5–18.1 µΜ), in addition to significantly high ABTS•+ scavenging activities. In vitro EGFR kinase assay for 6a, 6b, 7, and 8b as the most potent antitumour compounds showed that; compounds 6b, and 7 exhibited worthy EGFR inhibition activity with IC50 values of 0.56 and 1.6 µM, respectively, while compounds 6a and 8b showed good inhibition activity with IC50 values of 4.66 and 2.16 µM, respectively, compared with sorafenib reference drug (IC50 = 1.28 µM). Molecular modelling studies for compounds 6b, 7, and 8b were conducted to exhibit the binding mode towards EGFR kinase, which showed similar interaction with erlotinib.
first_indexed 2024-12-13T03:55:26Z
format Article
id doaj.art-ffe7cb284bb742a5b8b4fb2fc4452d4a
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-12-13T03:55:26Z
publishDate 2018-01-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-ffe7cb284bb742a5b8b4fb2fc4452d4a2022-12-22T00:00:38ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742018-01-0133150751810.1080/14756366.2018.14345191434519Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling studyWalaa M. El-Husseiny0Magda A.-A. El-Sayed1Naglaa I. Abdel-Aziz2Adel S. El-Azab3Esam R. Ahmed4Alaa A.-M. Abdel-Aziz5Mansoura UniversityMansoura UniversityMansoura UniversityKing Saud UniversityVacseraMansoura UniversityNew α,β-unsaturated ketones 4a,b; 5a–c; and 6a,b; as well as 4-H pyran 7; pyrazoline 8a,b; isoxazoline 9; pyridine 10–11; and quinoline-4-carboxylic acid 12a,b derivatives were synthesized and evaluated for in vitro antitumour activity against HepG2, MCF-7, HeLa, and PC-3 cancer cell lines. Antioxidant activity was investigated by the ability of these compounds to scavenge the 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS•+). Compounds 6a, 6b, 7, and 8b exhibited potent antitumour activities against all tested cell lines with [IC50] ≅5.5–18.1 µΜ), in addition to significantly high ABTS•+ scavenging activities. In vitro EGFR kinase assay for 6a, 6b, 7, and 8b as the most potent antitumour compounds showed that; compounds 6b, and 7 exhibited worthy EGFR inhibition activity with IC50 values of 0.56 and 1.6 µM, respectively, while compounds 6a and 8b showed good inhibition activity with IC50 values of 4.66 and 2.16 µM, respectively, compared with sorafenib reference drug (IC50 = 1.28 µM). Molecular modelling studies for compounds 6b, 7, and 8b were conducted to exhibit the binding mode towards EGFR kinase, which showed similar interaction with erlotinib.http://dx.doi.org/10.1080/14756366.2018.1434519α,β-Unsaturated ketoneantitumour activityantioxidant effectEGFR inhibitionmolecular docking
spellingShingle Walaa M. El-Husseiny
Magda A.-A. El-Sayed
Naglaa I. Abdel-Aziz
Adel S. El-Azab
Esam R. Ahmed
Alaa A.-M. Abdel-Aziz
Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study
Journal of Enzyme Inhibition and Medicinal Chemistry
α,β-Unsaturated ketone
antitumour activity
antioxidant effect
EGFR inhibition
molecular docking
title Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study
title_full Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study
title_fullStr Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study
title_full_unstemmed Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study
title_short Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study
title_sort synthesis antitumour and antioxidant activities of novel α β unsaturated ketones and related heterocyclic analogues egfr inhibition and molecular modelling study
topic α,β-Unsaturated ketone
antitumour activity
antioxidant effect
EGFR inhibition
molecular docking
url http://dx.doi.org/10.1080/14756366.2018.1434519
work_keys_str_mv AT walaamelhusseiny synthesisantitumourandantioxidantactivitiesofnovelabunsaturatedketonesandrelatedheterocyclicanaloguesegfrinhibitionandmolecularmodellingstudy
AT magdaaaelsayed synthesisantitumourandantioxidantactivitiesofnovelabunsaturatedketonesandrelatedheterocyclicanaloguesegfrinhibitionandmolecularmodellingstudy
AT naglaaiabdelaziz synthesisantitumourandantioxidantactivitiesofnovelabunsaturatedketonesandrelatedheterocyclicanaloguesegfrinhibitionandmolecularmodellingstudy
AT adelselazab synthesisantitumourandantioxidantactivitiesofnovelabunsaturatedketonesandrelatedheterocyclicanaloguesegfrinhibitionandmolecularmodellingstudy
AT esamrahmed synthesisantitumourandantioxidantactivitiesofnovelabunsaturatedketonesandrelatedheterocyclicanaloguesegfrinhibitionandmolecularmodellingstudy
AT alaaamabdelaziz synthesisantitumourandantioxidantactivitiesofnovelabunsaturatedketonesandrelatedheterocyclicanaloguesegfrinhibitionandmolecularmodellingstudy